Agnes Dechartres

Summary

Publications

  1. pmc Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review
    Nizar Ahmad
    Centre d Epidemiologie Clinique, Hopital Hotel Dieu, AP HP Assistance Publique des Hôpitaux de Paris, 1 Place du Parvis Notre Dame, Paris 75181, France
    Trials 11:20. 2010
  2. doi request reprint Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal
    Agnes Dechartres
    INSERM U738, Paris, France
    J Clin Epidemiol 62:695-702. 2009
  3. doi request reprint Outcomes of empirical eating disorder phenotypes in a clinical female sample: results from a latent class analysis
    Agnes Dechartres
    Maison des Adolescents, PSIGIAM, U669, INSERM, Paris, France
    Psychopathology 44:12-20. 2011
  4. doi request reprint Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed
    Agnes Dechartres
    Centre for Statistics in Medicine, University of Oxford, Oxford, UK
    J Clin Epidemiol 64:136-44. 2011
  5. pmc Knee arthroplasty: disabilities in comparison to the general population and to hip arthroplasty using a French national longitudinal survey
    Agnes Dechartres
    INSERM, U738, Paris, France
    PLoS ONE 3:e2561. 2008
  6. doi request reprint Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis
    Mariette Baud
    INSERM Unit 938, CdR Saint Antoine, Paris, France
    J Thorac Cardiovasc Surg 145:1305-11. 2013
  7. doi request reprint In obese and non-obese adults, the cis-regulatory rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes
    Karine Clement
    Endocrinology and Nutrition Department, Pitie Salpetriere Hospital, Paris, France
    Mol Genet Metab 96:129-32. 2009
  8. doi request reprint Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study
    Agnes Dechartres
    U738 INSERM, Paris, France
    Ann Intern Med 155:39-51. 2011
  9. pmc Influence of trial sample size on treatment effect estimates: meta-epidemiological study
    Agnes Dechartres
    INSERM, U738, Paris, France
    BMJ 346:f2304. 2013
  10. pmc Geographical representativeness of published and ongoing randomized controlled trials. The example of: Tobacco consumption and HIV infection
    Nizar Ahmad
    INSERM, U738, Paris, France
    PLoS ONE 6:e16878. 2011

Collaborators

Detail Information

Publications22

  1. pmc Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review
    Nizar Ahmad
    Centre d Epidemiologie Clinique, Hopital Hotel Dieu, AP HP Assistance Publique des Hôpitaux de Paris, 1 Place du Parvis Notre Dame, Paris 75181, France
    Trials 11:20. 2010
    ..e., whether the results of a trial can be reasonably applied or generalized to a definable group of patients in a particular setting in routine practice, also called external validity or generalisability)...
  2. doi request reprint Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal
    Agnes Dechartres
    INSERM U738, Paris, France
    J Clin Epidemiol 62:695-702. 2009
    ..We aimed to assess the reporting and functioning of ACs (synonyms: clinical event committees, endpoint committees) in clinical trials...
  3. doi request reprint Outcomes of empirical eating disorder phenotypes in a clinical female sample: results from a latent class analysis
    Agnes Dechartres
    Maison des Adolescents, PSIGIAM, U669, INSERM, Paris, France
    Psychopathology 44:12-20. 2011
    ..To empirically classify phenotypes of eating disorders (ED) using latent class analysis (LCA), and to validate this classification based on clinical outcomes...
  4. doi request reprint Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed
    Agnes Dechartres
    Centre for Statistics in Medicine, University of Oxford, Oxford, UK
    J Clin Epidemiol 64:136-44. 2011
    ..Many reviews specifically aimed to assess the quality of randomized controlled trials (RCTs). We evaluated the quality of reporting in such reviews...
  5. pmc Knee arthroplasty: disabilities in comparison to the general population and to hip arthroplasty using a French national longitudinal survey
    Agnes Dechartres
    INSERM, U738, Paris, France
    PLoS ONE 3:e2561. 2008
    ..A secondary objective was to compare the level of disabilities of people with knee to people with hip arthroplasty...
  6. doi request reprint Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis
    Mariette Baud
    INSERM Unit 938, CdR Saint Antoine, Paris, France
    J Thorac Cardiovasc Surg 145:1305-11. 2013
    ..The objective of this study was to evaluate long-term survival and prognostic factors in patients with malignant pleural mesothelioma...
  7. doi request reprint In obese and non-obese adults, the cis-regulatory rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes
    Karine Clement
    Endocrinology and Nutrition Department, Pitie Salpetriere Hospital, Paris, France
    Mol Genet Metab 96:129-32. 2009
    ..Allele C of rs361072 is associated with a protection from IR in obese and non-obese adults, but has no significant effect, however, on diabetes risk in obese or non-obese Europeans...
  8. doi request reprint Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study
    Agnes Dechartres
    U738 INSERM, Paris, France
    Ann Intern Med 155:39-51. 2011
    ..A recent study suggested that results of single-center trials are frequently contradicted when similar trials are performed in multicenter settings...
  9. pmc Influence of trial sample size on treatment effect estimates: meta-epidemiological study
    Agnes Dechartres
    INSERM, U738, Paris, France
    BMJ 346:f2304. 2013
    ..To assess the influence of trial sample size on treatment effect estimates within meta-analyses...
  10. pmc Geographical representativeness of published and ongoing randomized controlled trials. The example of: Tobacco consumption and HIV infection
    Nizar Ahmad
    INSERM, U738, Paris, France
    PLoS ONE 6:e16878. 2011
    ..This study aimed to compare where research is conducted to where research is needed for 2 public health priorities: tobacco consumption and HIV infection...
  11. doi request reprint Mycobacterium genavense infections: a retrospective multicenter study in France, 1996-2007
    Pierre Charles
    Universite Paris Descartes, Hopital Necker Enfants Malades, Paris, France
    Medicine (Baltimore) 90:223-30. 2011
    ..The 1-year survival rate was 72%.The prognosis of M. genavense infection in HIV-infected patients has dramatically improved with HAART. Clinical presentations in HIV and non-HIV immunocompromised patients were similar...
  12. pmc Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study
    Aïda Bafeta
    INSERM U738, Paris, France
    BMJ 344:e813. 2012
    ..To compare estimates of intervention effects between single centre and multicentre randomised controlled trials with continuous outcomes...
  13. pmc Reporting of sample size calculation in randomised controlled trials: review
    Pierre Charles
    INSERM, U738, Paris, France
    BMJ 338:b1732. 2009
    ..To assess quality of reporting of sample size calculation, ascertain accuracy of calculations, and determine the relevance of assumptions made when calculating sample size in randomised controlled trials...
  14. ncbi request reprint Evolution of disability in adults with hip arthroplasty: a national longitudinal study
    Agnes Dechartres
    INSERM, U738, Universite Paris 7, UFR de Medecine, AP HP Hôpital Bichat, Département d Epidémiologie, Biostatistique et Recherche Clinique, Paris, France
    Arthritis Rheum 57:364-71. 2007
    ..To describe disability in individuals with hip arthroplasty and its evolution over 2 years compared with that in the general population, and to compare the degree of disability between subjects with recent and older hip arthroplasty...
  15. pmc Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals
    Carolina Riveros
    INSERM U738, Paris, France Université Paris Descartes Sorbonne Paris Cité, Paris, France Centre d épidémiologie clinique, Hopital Hotel Dieu, Assistance Publique Hopitaux de Paris, Paris, France
    PLoS Med 10:e1001566; discussion e1001566. 2013
    ..gov within 1 y after trial completion. We compared the timing and completeness of results of drug trials posted at ClinicalTrials.gov and published in journals...
  16. doi request reprint Reporting of corticosteroid use in systemic disease trials: evidence from a systematic review of the potential impact on treatment effect
    Christian Pagnoux
    INSERM U738, Universite Paris Diderot, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, Paris, France
    Arthritis Care Res (Hoboken) 62:1002-8. 2010
    ..To study how corticosteroid therapy is planned and described in reports of systemic disease trials and estimate the impact of the between-arm difference in corticosteroid dose on treatment effect...
  17. doi request reprint Public availability of results of trials assessing cancer drugs in the United States
    Thi Anh Hoa Nguyen
    Assistance Publique Hopitaux de Paris, Hopital Hotel Dieu, Paris, France
    J Clin Oncol 31:2998-3003. 2013
    ..gov, as required by the Food and Drug Administration Amendments Act (FDAAA), or are published in journals...
  18. pmc Delphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention
    Agnes Dechartres
    UMR S 738, INSERM, Paris, France
    PLoS ONE 6:e18461. 2011
    ..To weight ischemic and bleeding events according to their severity to be used in a composite outcome in RCTs in the field of thrombosis prevention...
  19. pmc Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review
    Amélie van der Meersch
    INSERM, U738, Paris, France
    PLoS ONE 6:e23611. 2011
    ..Generic drugs are used by millions of patients for economic reasons, so their evaluation must be highly transparent...
  20. doi request reprint Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer
    Marco Alifano
    Department of Thoracic Surgery, Hotel Dieu Hospital, APHP, Universite Paris Descartes, Paris, France
    J Thorac Cardiovasc Surg 142:1161-7. 2011
    ..This study aimed to determine whether preresection serum CRP level independently predicts survival among patients with resectable non-small cell lung cancer...
  21. ncbi request reprint A single-nucleotide polymorphism in the p110beta gene promoter is associated with partial protection from insulin resistance in severely obese adolescents
    Catherine Le Stunff
    Department of Pediatric Endocrinology, Pôle d Endocrinologie Enfants Adultes Cochin St Vincent de Paul, APHP, Hopital Saint Vincent de Paul, Paris V University, Paris, France
    J Clin Endocrinol Metab 93:212-5. 2008
    ..We studied the p110beta gene as a candidate gene for association with insulin resistance (IR) and fasting glycemia in severely obese children...
  22. pmc Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review
    Isabelle Boutron
    INSERM U738, Paris, France
    PLoS Med 3:e425. 2006
    ....